SS-31 Peptide Dose Per Day: What Research Can and Cannot Tell You

There is no established daily SS-31 peptide dose for general wellness, energy, or longevity. SS-31 peptide, also called elamipretide, has been studied in specific disease protocols, but online dosing ranges are not approved medical guidance. Do not self-dose; discuss eligibility, risks, and monitoring with a licensed clinician.

What is the short answer on SS-31 peptide dose per day?

The short answer: there is no universal SS-31 dose per day for general mitochondrial support. Published and registered research protocols study elamipretide in defined conditions, with defined routes and monitoring, not as an open-ended wellness peptide.

Quick facts: SS-31 dosing, approval status, and evidence limits

SS-31 dosing cannot be separated from the clinical context. A trial in primary mitochondrial myopathy, a trial in Barth syndrome, and an acute-care heart or kidney study may use different routes, endpoints, visit schedules, and safety checks 3, 4, 5. That is why a number copied from a forum is not the same as medical guidance.

Why online “daily dose” ranges can be misleading

Online peptide guides often mix clinical-trial doses, animal-study doses, and non-medical protocols. That is risky because route matters: a subcutaneous injection, intravenous infusion, eye drop, nanoparticle delivery system, or lab-cell exposure can produce very different exposure in the body 2, 6.

What is SS-31, also called elamipretide?

SS-31 is a small mitochondria-targeted peptide. Its sequence is often written as D-Arg-Dmt-Lys-Phe-NH2, and it is designed to concentrate near the inner mitochondrial membrane rather than float broadly through the cell 1.

Names to know: SS-31, elamipretide, MTP-131, Bendavia, and Szeto-Schiller peptide 31

The same molecule may appear under several names: SS-31, elamipretide, MTP-131, Bendavia, Szeto-Schiller peptide 31, or D-Arg-Dmt-Lys-Phe-NH2 1. These names can make searches confusing, especially when a wellness article, a trial registry, and a mechanistic paper use different labels.

What kind of peptide is SS-31?

SS-31 is a tetrapeptide, meaning it is made of four amino-acid building blocks. It is described as a mitochondria-targeted peptide because its chemical structure supports interactions with the inner mitochondrial membrane 1.

How SS-31 differs from general antioxidant supplements

General antioxidant supplements act more broadly and do not reliably concentrate inside mitochondria. SS-31 is different because researchers designed it to localize near mitochondrial membranes and interact with cardiolipin, a fat-like molecule involved in electron transport chain function 1.

How is SS-31 thought to work in mitochondria?

The main idea is that SS-31 may help stabilize mitochondrial membrane function under stress. Research focuses on cardiolipin, reactive oxygen species, ATP production, and mitochondrial permeability transition processes, but these mechanisms do not prove a general human longevity benefit 1.

Cardiolipin and the inner mitochondrial membrane

Cardiolipin is a key lipid in the inner mitochondrial membrane. It helps organize parts of the electron transport chain, the system cells use to help make ATP, which is the cell’s main energy currency 1.

Reactive oxygen species, ATP production, and mitochondrial stress

When mitochondria are stressed, they may produce more reactive oxygen species, often called ROS. SS-31 has been investigated for lowering mitochondrial ROS production and protecting against mitochondrial depolarization in experimental models 1.

What preclinical models can show—and what they cannot prove in humans

Preclinical studies can show whether a mechanism looks plausible in cells or animals. They cannot prove that a peptide improves energy, slows aging, or extends healthy life in people. For example, a zebrafish study of SS-31-conjugated nanoparticles looked at gentamicin-related hair-cell injury and mitochondrial targeting, not human wellness dosing 2.

What daily doses have been studied in research?

Research doses vary because clinical trials are built around a specific question. A trial dose is not a recommendation for an individual person, and it is not a general wellness protocol.

Why dose depends on the condition, route, formulation, and trial protocol

Elamipretide has appeared in studies using different routes, including subcutaneous and intravenous approaches, depending on the disease and study design 3, 5, 7. Route matters because it changes absorption, peak levels, monitoring needs, and potential side effects.

Dosing chart: separate clinical-trial dosing from non-medical internet protocols

Why animal or cell-study doses should not be converted into human self-dosing

Animal and cell studies often use routes, exposure levels, and delivery systems that do not match human use. In the zebrafish study, the intervention was a drug-delivery system using SS-31-conjugated nanoparticles, not plain SS-31 self-injection in people 2.

Is SS-31 approved for longevity, fatigue, or general mitochondrial support?

No established approval or guideline supports SS-31 for general longevity, fatigue, or mitochondrial optimization. Any use outside a specific approved label or clinical trial should be treated as investigational or off-label, and patients should verify the current label status through official FDA sources 8.

Approved indications versus off-label or investigational use

An approved indication means a drug has FDA-reviewed labeling for a defined use, dose, population, and safety information. A plausible mechanism, a trial registry entry, or a peptide-clinic protocol is not the same as an approved indication 8.

What counts as human clinical evidence

Human clinical evidence includes phase 1 safety studies, randomized trials, open-label extension studies, and disease-specific registries. These can be useful, but they answer narrow questions, such as whether elamipretide affects a defined endpoint in a defined disease group 3, 4, 6.

Why a plausible mitochondrial mechanism is not proof of a longevity benefit

Mitochondria are central to energy biology, but that does not mean every mitochondria-targeted compound improves human lifespan or healthspan. The kidney review notes promising experimental models but also states that renal evidence remains limited and mechanisms are still being explored 1.

What are the known safety questions with SS-31?

The honest answer is that SS-31 safety depends on the person and the protocol. Human studies are more informative than animal work, but they still may not capture long-term, unsupervised, combined, or wellness use.

Adverse effects reported in human research should be summarized cautiously

Trial registries and publications track adverse events under controlled conditions, with eligibility rules and monitoring visits 3, 4, 6. That does not tell us the full risk profile for people buying research peptides online or combining multiple compounds without medical oversight.

Special caution for people with kidney, heart, metabolic, or complex chronic conditions

SS-31 has been investigated in kidney-disease models such as ischemia-reperfusion injury, acute kidney injury, chronic kidney disease, diabetic nephropathy, and other renal contexts 1. That research interest should not be read as a green light for people with kidney, heart, or metabolic disease to self-experiment.

Why compounded or research-use peptides require extra scrutiny

The biggest safety split is licensed versus unlicensed access. A licensed clinician and a state-licensed 503A pharmacy create a different safety environment than no-prescription “research chemical” vendors, where identity, sterility, potency, and monitoring may be unclear. Compounded medications and compounded peptides are not FDA-approved.

Does Chia offer SS-31 peptide?

No. Chia does not currently offer SS-31 or elamipretide. We cover it here because patients ask about mitochondrial peptides and daily dosing, and we want the answer to be clear: SS-31 is education-only at Chia.

Chia does not currently offer SS-31 or elamipretide

SS-31 is not in our live treatment catalog, so we do not link it to a product page or present it as something available through Chia. If you are considering any peptide, the safest starting point is a licensed clinical review rather than a self-made dosing plan.

Longevity-related treatments Chia does offer: NAD+, glutathione, sermorelin, GHK-Cu cream, and Foundation Longevity

For patients who want a clinician-reviewed longevity conversation, Chia does offer NAD+ as injection or nasal spray, glutathione as injection or nasal spray, sermorelin as injection, nasal spray, or tablets, and GHK-Cu cream. We also offer Foundation Longevity, which combines sermorelin injection, NAD+ injection, and glutathione injection in one protocol.

How Chia’s online clinician review works for treatments that are in the live catalog

For treatments Chia does offer, care starts with a short online health questionnaire. A licensed US provider reviews your history and prescribes only when clinically appropriate; a prescription is never guaranteed. If prescribed, medications are compounded by state-licensed US 503A pharmacies and shipped to your door, with provider-guided dosing and portal messaging for follow-up.

What should you ask a clinician before using any mitochondrial peptide?

Before using any mitochondrial peptide, ask whether there is a real diagnosis, a clear goal, and a monitoring plan. A daily peptide dose without a medical reason is not a safe plan.

Questions about diagnosis, goals, labs, medications, and contraindications

• What condition or symptom are we trying to evaluate?
• Is there human evidence for this goal, or only animal and cell evidence?
• What labs or records should be reviewed first?
• Could this interact with my medications, supplements, heart history, kidney function, pregnancy status, or metabolic conditions?
• What side effects should trigger stopping and seeking care?

Questions about pharmacy source, prescription status, and monitoring

• Is this being prescribed by a licensed clinician after a real evaluation?
• Is the pharmacy state-licensed, and is the product made for a specific patient prescription?
• What monitoring visits or check-ins are planned?
• How will the clinician decide whether to continue, stop, or change therapy?
• Is the product compounded, research-use only, or FDA-approved for a specific labeled use?

When to avoid self-experimentation

Avoid self-experimentation if you are pregnant or trying to become pregnant, have kidney or heart disease, have a complex neurologic or metabolic condition, take multiple prescription drugs, or bought a peptide from a no-prescription vendor. Those are situations where clinician oversight matters.

FAQ

Keep reading

Peptides

SS-31 Peptide (Elamipretide): What It Is, How It Works, and What the Evidence Shows

Longevity Peptides

SS-31 Peptide Dose: What the Research Actually Shows

Longevity

NAD+ and Peptides: What They Are, How They Differ, and What They Do